Organizer
Waters Corporation
Waters Corporation
Waters Corporation, the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years.
Tags
LC/MS
LC/MS/MS
LC/TOF
LC/HRMS
LinkedIn Logo

Enhanced Sensitivity and Selectivity with Tof MRM

RECORD | Already taken place Th, 18.9.2025
Can high-res MS match triple quad sensitivity? See how Xevo MRT MS with Tof MRM and MS Quan delivers powerful performance for quantitation across dynamic ranges.
Go to the webinar
Waters Corporation: XEVO MRT in Action - Demo Series
Waters Corporation: XEVO MRT in Action - Demo Series

High resolution mass spectrometry is being asked to step up and achieve the levels of sensitivity akin to that of tandem quadrupole mass spectrometry. The question is…can it deliver? During this session we’ll look at the acquisition and processing of Tof MRM on the Xevo MRT MS. The system incorporates multi-reflecting time-of-flight technology that achieves excellent levels of sensitivity over a wide dynamic range, ideal for qualitative and quantitative applications. We’ll assess the results in the MS Quan Application, part of the waters_connect Software Solution, for efficient data processing and data review. And yes – the Xevo MRT MS can deliver

Who Should Attend:
  • Learn about the operation of the novel Xevo MRT MS technology and see it in Action!
  • Discover how the system integrates into MS Quan Application for streamlined data processing and review of Tof MRM data sets 
  • Assess the levels of performance with the detection of low level analytes over a wide dynamic range, ideal for targeted (and untargeted) applications  

The session will conclude with a live Q&A where members of the Waters Xevo MRT team will be on hand to answer all of your questions. 

Presenter: Matt Daly PhD (Senior Applications Chemist - Xevo MRT Program, Waters Corporation)

Matthew Daly joined Waters in September 2022 and is currently working as a Senior Scientist in the Xevo MRT Science Team. Matthew’s main focus and area of expertise lies in LC-MS discovery bottom-up proteomics using high-resolution mass spectrometry with a particular interest in biomarker discovery and translation through to targeted applications.

Matthew obtained a BSc Hons from Swansea University in Biochemistry and Genetics before completing a MSc by Research in Nanotechnology at the same institution. After a brief time in industry developing food allergen ELISAs, Matthew returned to academia to complete his PhD in Biochemistry at the University of Manchester where he developed a targeted mass spectrometry method to detect and quantify gluten in foods.

Waters Corporation
LinkedIn Logo
 

Related content

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics

Oligonucleotide Analysis Using the Agilent InfinityLab Pro iQ and Altura Oligo HPH-C18 Column

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ, Consumables, LC columns
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Metabolomics
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike